{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 mutations are the most common genetic cause of parkinsonism, with G2019S being the most common variant. The study models DA neuron loss, locomotion deficits, and mitochondrial dysfunction.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism as LRRK2-related neurodegeneration with DA neuron loss and mitochondrial sensitivity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Transgenic Drosophila over-expressing human LRRK2 alleles were used to model DA neuron loss, locomotion deficits, lifespan, and rotenone sensitivity.",
          "judgment": "Yes",
          "reasoning": "Drosophila models are standard for studying Parkinson's disease, and the assays directly model key features of the disease mechanism."
        },
        {
          "step_name": "Step 3a: Basic controls and replicates",
          "extracted_paper_info": "Wild-type LRRK2 (control) and mutant variants (G2019S, Y1699C, G2385R) were compared. Experiments were conducted in transgenic flies.",
          "judgment": "Yes",
          "reasoning": "Wild-type LRRK2 was used as a negative control. The study compared mutant variants to wild-type, implying replicates."
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "No additional pathogenic/benign variant controls were explicitly stated. Only wild-type and the three mutant variants were tested.",
          "judgment": "No",
          "reasoning": "The study did not use known pathogenic or benign variants beyond the tested mutants and wild-type."
        },
        {
          "step_name": "Step 4a: Statistical analyses",
          "extracted_paper_info": "Statistical details (e.g., p-values, effect sizes) are not explicitly provided in the abstract/introduction. Co-expression of parkin reduced neurodegeneration, but quantitative OddsPath is not mentioned.",
          "judgment": "No",
          "reasoning": "Lack of explicit statistical methods or OddsPath calculations prevents robust statistical evaluation."
        },
        {
          "step_name": "Step 4b: Total control variant count",
          "extracted_paper_info": "Three mutant variants (G2019S, Y1699C, G2385R) and one wild-type variant were tested.",
          "judgment": "Yes",
          "reasoning": "Total control variants (3 pathogenic + 1 benign) = 4, which is fewer than 11."
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Same as above.",
          "judgment": "Yes",
          "reasoning": "Same disease mechanism as G2019S."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Same as above.",
          "judgment": "Yes",
          "reasoning": "Same assays and disease modeling."
        },
        {
          "step_name": "Step 3a: Basic controls and replicates",
          "extracted_paper_info": "Same as above.",
          "judgment": "Yes",
          "reasoning": "Same controls and replicates."
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "Same as above.",
          "judgment": "No",
          "reasoning": "Same reasoning as G2019S."
        },
        {
          "step_name": "Step 4a: Statistical analyses",
          "extracted_paper_info": "Same as above.",
          "judgment": "No",
          "reasoning": "Same reasoning as G2019S."
        },
        {
          "step_name": "Step 4b: Total control variant count",
          "extracted_paper_info": "Same as above.",
          "judgment": "Yes",
          "reasoning": "Same reasoning as G2019S."
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "R",
          "position": "2385"
        },
        "variant_string_id": "LRRK2 G2385R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Same as above.",
          "judgment": "Yes",
          "reasoning": "Same disease mechanism as G2019S."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Same as above.",
          "judgment": "Yes",
          "reasoning": "Same assays and disease modeling."
        },
        {
          "step_name": "Step 3a: Basic controls and replicates",
          "extracted_paper_info": "Same as above.",
          "judgment": "Yes",
          "reasoning": "Same controls and replicates."
        },
        {
          "step_name": "Step 3c: Variant controls",
          "extracted_paper_info": "Same as above.",
          "judgment": "No",
          "reasoning": "Same reasoning as G2019S."
        },
        {
          "step_name": "Step 4a: Statistical analyses",
          "extracted_paper_info": "Same as above.",
          "judgment": "No",
          "reasoning": "Same reasoning as G2019S."
        },
        {
          "step_name": "Step 4b: Total control variant count",
          "extracted_paper_info": "Same as above.",
          "judgment": "Yes",
          "reasoning": "Same reasoning as G2019S."
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    }
  ]
}